A panel of differentially expressed proteins, stratified by FAT1 mutation status, were identified to be involved in the activation of growth factors and signaling pathways with potential effect on cancer cell proliferation, metastasis, angiogenesis, and immunomodulation (Figure 1). This evidence concerns the gene FAT1 and cancer.